Company / Working Capital
Bionano Genomics, Inc. Working Capital History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$22.4M
FY2025
5-year range
$2.1M / $250.6M
FY2021-FY2025
Trend
+946.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital changed +946% YoY in FY2025, a notable deviation from the 7-year average annual change of +444%.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of -9.9%.
Declined from $40M to $22M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -43.0%
- 5-Year CAGR
- -9.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -9.9%, indicating a declining trend.
- In FY2025, working capital increased 946.3% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.4M | +946.3% |
| FY2024 | $2.1M | -94.6% |
| FY2023 | $40.1M | -67.0% |
| FY2022 | $121.4M | -51.5% |
| FY2021 | $250.6M | +562.1% |
| FY2020 | $37.8M | +1901.0% |
| FY2019 | $1.9M | -89.8% |
| FY2018 | $18.5M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026